A carregar...

Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma

Aberrant activation of the Janus Kinase (JAK)/Signal Activator of Transcription (STAT) pathway has been implicated in glioblastoma (GBM) progression. To develop a therapeutic strategy to inhibit STAT-3 signaling, we have evaluated the effects of AZD1480, a pharmacological inhibitor of JAK1 and JAK2....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: McFarland, Braden C., Ma, Jing-Yuan, Langford, Catherine P., Gillespie, G. Yancey, Yu, Hao, Zheng, Ying, Nozell, Susan E., Huszar, Dennis, Benveniste, Etty N.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3237864/
https://ncbi.nlm.nih.gov/pubmed/22027691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-11-0480
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!